Adaptimmune Therapeutics
ADAP
#9324
Rank
C$94.39 M
Marketcap
$0.37
Share price
-20.31%
Change (1 day)
-80.29%
Change (1 year)

Market capitalization of Adaptimmune Therapeutics (ADAP)

Market cap: C$94.39 Million

As of April 2025 Adaptimmune Therapeutics has a market cap of C$94.39 Million. This makes Adaptimmune Therapeutics the world's 9324th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Adaptimmune Therapeutics from 2015 to 2025

End of year Market Cap

Year Marketcap Change
2025C$94.39 M-56.43%
2024C$0.21 B-9.31%
2023C$0.23 B-26.4%
2022C$0.32 B-56.52%
2021C$0.74 B-29.83%
2020C$1.06 B545.43%
2019C$0.16 B-79.88%
2018C$0.81 B4.1%
2017C$0.78 B104.23%
2016C$0.38 B-67.47%
2015C$1.18 B

End of Day market cap according to different sources

On Apr 5th, 2025 the market cap of Adaptimmune Therapeutics was reported to be:

C$0.56 Billion
by Nasdaq info icon info icon
C$94.39 Million
by CompaniesMarketCap info icon info icon
C$94.39 Million
by Yahoo Finance info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
C$1.42 B 1,411.74%๐Ÿ‡บ๐Ÿ‡ธ USA
C$21.6 M-77.11%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.68 B 629.80%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
C$13.75 B 14,473.36%๐Ÿ‡บ๐Ÿ‡ธ USA